F-15599

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameF-15599
Drug Alias NameF-15599NLX-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsSchizophreniaCognition DisordersMood Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeurolixisPierre Fabre Group
Inactive CompaniesN/A
Active IndicationsSchizophreniaCognition DisordersMood Disorders +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A